Literature DB >> 11016877

Influenza, pneumococcal, and tetanus toxioid vaccination of adults--United States, 1993-7.

J A Singleton1, S M Greby, K G Wooten, F J Walker, R Strikas.   

Abstract

PROBLEM/CONDITION: An increasing proportion of adults have received recommended vaccinations against influenza, pneumococcal infection, and tetanus. However, in 1995, fewer than 60% of adults were vaccinated as recommended. REPORTING PERIOD COVERED: 1993-1997. DESCRIPTION OF SYSTEM: Data were obtained from the state-based Behavioral Risk Factor Surveillance System (BRFSS) for 1993, 1995, and 1997 and from the National Health Interview Survey (NHIS) for 1995 to describe national, regional, and state-specific patterns of use of influenza and pneumococcal vaccines and tetanus toxoid among noninstitutionalized adults aged > or = 18 years.
RESULTS: Among adults aged > or = 65 years in 1995, 58% reported receiving an influenza vaccination during the previous 12 months, and 34% reported ever receiving a pneumococcal vaccination. In this age group, non-Hispanic whites were more likely to report receipt of influenza (61%) and pneumococcal vaccines (36%) than non-Hispanic blacks (40% and 22%, respectively) and Hispanics (50% and 23%, respectively). Among the 50 states and the District of Columbia, the median vaccination level among older adults (i.e., persons aged > or = 65 years) increased from 51% in 1993 to 66% in 1997 for influenza vaccine, and from 28% in 1993 to 46% in 1997 for pneumococcal vaccine. Adults with chronic medical conditions had low vaccination levels. Those aged 50-64 years were more likely than those aged 18-49 years to report influenza (38% versus 20%) and pneumococcal vaccination (20% versus 12%). In 1995, the proportion of adults who reported receiving a tetanus vaccination during the previous 10 years decreased with age, from 65% among those aged 18-49 years to 54% among those aged 50-64 years and to 40% among those aged > or = 65 years. In each age group, women were less likely than men to report receiving tetanus toxoid; and among adults aged > or = 65 years, Hispanics and Asians/Pacific Islanders were least likely among all racial/ethnic groups to report receiving tetanus toxoid.
INTERPRETATION: By 1995, the Healthy People 2000 objective to increase to at least 60% the proportion of persons aged > or = 65 years who had received annual influenza vaccination had been achieved among non-Hispanic whites (objective 20.11). However, substantial improvement is needed among non-Hispanic blacks, Hispanics, and adults aged < 65 years with high-risk medical conditions. PUBLIC HEALTH ACTIONS: Continued surveillance of vaccine coverage among adults will direct attention to undervaccinated populations that may be disproportionately affected by vaccine-preventable diseases. Vaccination coverage data can be used to guide efforts to increase awareness among health-care providers and the public about the benefits of vaccination, establish systems to ensure that every contact with the health-care system is used to update vaccinations, and further support financial mechanisms to increase vaccine delivery.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11016877

Source DB:  PubMed          Journal:  MMWR CDC Surveill Summ


  14 in total

1.  Racial/ethnic differences in influenza vaccination coverage in high-risk adults.

Authors:  Leonard E Egede; Deyi Zheng
Journal:  Am J Public Health       Date:  2003-12       Impact factor: 9.308

2.  Uptake of pneumococcal polysaccharide vaccine in at-risk populations in England and Wales 1999-2005.

Authors:  R G Pebody; J Hippisley-Cox; S Harcourt; M Pringle; M Painter; G Smith
Journal:  Epidemiol Infect       Date:  2007-04-20       Impact factor: 2.451

3.  Correlates of seasonal flu vaccination among U.S. home health aides.

Authors:  Alberto Juan Caban-Martinez; Anna Arlinghaus; Silje E Reme
Journal:  Vaccine       Date:  2012-11-10       Impact factor: 3.641

4.  Pneumococcal Vaccination in Adults.

Authors:  Tsering Y Sherpa; Howard L Leaf
Journal:  Curr Infect Dis Rep       Date:  2005-05       Impact factor: 3.725

5.  Nicotine vaccines: will smokers take a shot at quitting?

Authors:  Amy E Leader; Caryn Lerman; Joseph N Cappella
Journal:  Nicotine Tob Res       Date:  2010-02-25       Impact factor: 4.244

6.  Understanding the reasons for the underuse of pneumococcal vaccination by community-dwelling older African Americans.

Authors:  Linda G Jones; Yan Zhang; Mustafa I Ahmed; O James Ekundayo; Shamima Akhter; Patricia Sawyer; Inmaculada Aban; Richard V Sims; Ali Ahmed
Journal:  J Am Geriatr Soc       Date:  2010-12       Impact factor: 5.562

7.  [Coverage of anti-tetanus vaccinations in adults in Canada-year 2002. ].

Authors:  Norbert Coulibaly; Gaston De Serres
Journal:  Can J Public Health       Date:  2004 Nov-Dec

Review 8.  Pneumococcal vaccination and revaccination of older adults.

Authors:  Andrew S Artz; William B Ershler; Dan L Longo
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

9.  Influenza vaccination of persons with cardiovascular disease in the United States.

Authors:  James A Singleton; Pascale Wortley; Peng-Jun Lu
Journal:  Tex Heart Inst J       Date:  2004

10.  Factors associated with human papillomavirus vaccination among young adult women in the United States.

Authors:  Walter W Williams; Peng-Jun Lu; Mona Saraiya; David Yankey; Christina Dorell; Juan L Rodriguez; Deanna Kepka; Lauri E Markowitz
Journal:  Vaccine       Date:  2013-04-30       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.